|Articles|April 28, 2016
OmniComm Signs Agreement with CROMSOURCE
Advertisement
OmniComm announced the signing of a five-year agreement with CROMSOURCE. OmniComm’s TrialMaster EDC suite will be used for the collection of clinical data in trials spanning all clinical phases and therapeutic areas.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Thermo Fisher, Lundbeck Announce New OpenAI Partnerships Advancing AI in Drug Development
2
Building Broader Investigator Networks to Advance Global Breast Cancer Research
3
dashClinical: Real-Time Participant Payments
4
ACT Brief: AI Expands Global Site Leadership as Ozempic Shows Potential to Reverse Biological Age
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
